Moreover, the ALD group was characterized by higher serum levels of IL-6 and G-CSF (Figure 2E), while the NAFLD group showed higher levels of LIF and CCL25 (Figure 2F). Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.